Skip to main content
Livermore
Livermore
ZHEN

Parallel Advisors, LLC

SEC CIK
0001690010
Latest filing
Aug 5, 2026

NKTR holding history

Nektar Therapeutics in every 13F filed by Parallel Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NKTR overviewAll 13F holders of NKTRFull Q2 2026 holdings

Shares (Q2 2026)
1,047
Value
$73.1K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of NKTR by Parallel Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,047$73.1K<0.1%−6−0.6%ReducedHolders
Q1 20261,053$75.8K<0.1%00.0%UnchangedHolders
Q4 20251,053$44.5K<0.1%00.0%UnchangedHolders
Q3 20251,053$59.9K<0.1%00.0%UnchangedHolders
Q2 20251,053$27.2K<0.1%00.0%UnchangedConverted for a 1-for-15 splitHolders
Q1 202515,820$10.8K<0.1%00.0%UnchangedHolders
Q4 202415,820$14.7K<0.1%00.0%UnchangedHolders
Q3 202415,820$20.6K<0.1%00.0%UnchangedHolders
Q2 202415,820$19.6K<0.1%00.0%UnchangedHolders
Q1 202415,820$14.8K<0.1%00.0%UnchangedHolders
Q4 202315,820$8.94K<0.1%00.0%UnchangedHolders
Q3 202315,820$9.42K<0.1%00.0%UnchangedHolders
Q2 202315,820$9.10K<0.1%00.0%UnchangedHolders
Q1 202315,820$11.1K<0.1%−993−5.9%ReducedHolders
Q4 202216,813$38.0K<0.1%−1,103−6.2%ReducedHolders
Q3 202217,916$57.0K<0.1%+238+1.3%AddedHolders
Q2 202217,678$67.0K<0.1%+735+4.3%AddedHolders
Q1 202216,943$94.0K<0.1%−580−3.3%ReducedHolders
Q4 202117,523$237.0K<0.1%+350+2.0%AddedHolders
Q3 202117,173$308.0K<0.1%+377+2.2%AddedHolders
Q2 202116,796$288.0K<0.1%−44−0.3%ReducedHolders
Q1 202116,840$337.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.